awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q39158415-2AB43273-0DD0-421E-AB0B-6C30DB496488
Q39158415-2AB43273-0DD0-421E-AB0B-6C30DB496488
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39158415-2AB43273-0DD0-421E-AB0B-6C30DB496488
Advances in emerging drugs for the treatment of neuroblastoma.
P2860
Q39158415-2AB43273-0DD0-421E-AB0B-6C30DB496488
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39158415-2AB43273-0DD0-421E-AB0B-6C30DB496488
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
31f3b8562d3ccfdc365771669a40a03f4c6c2101
P2860
Pediatric phase I trial and pharmacokinetic study of MLN8237, an investigational oral selective small-molecule inhibitor of Aurora kinase A: a Children's Oncology Group Phase I Consortium study.